By Trista Morrison, BioWorld Insight
Read More…BioVista: Artificial Intelligence for Discovery What happens when you combine the vision of Anadys Pharmaceuticals Inc…You get BioVista Inc., a start-up with a drug profiling platform that goes way beyond data mining to identify new uses for existing compounds…BioVista also has generated an internal pipeline comprising more than 30 repurposed generic compounds, the lead two of which are in preclinical studies for multiple sclerosis…
The PDF is also available here.